Cutaneous vascular response and its role in the efficacy of laser-based aesthetic procedures

INTRODUCTION

Laser-based aesthetic procedures have become a cornerstone of modern dermatologic practice, offering non-invasive or minimally invasive treatments for a wide range of conditions including vascular lesions, pigmentary disorders, skin rejuvenation, and hair removal. The success of these treatments is often dependent on the complex interactions between laser energy and biological tissues, particularly the vascular structures of the skin. Among these interactions, the cutaneous vascular response plays a critical role in mediating both immediate and long-term outcomes of laser interventions.

The principle of selective photothermolysis, first described in the late 20th century, underpins many vascular laser therapies. It relies on the precise targeting of chromophores, such as oxyhemoglobin, using specific laser wavelengths and pulse durations that maximize absorption while sparing surrounding tissue. This method results in targeted photocoagulation of blood vessels without causing widespread epidermal damage.¹ The cutaneous vasculature thus acts not only as a target but also as a mediator of the wound healing cascade that follows laser exposure.

Vascular dynamics in the skin are influenced by various intrinsic and extrinsic factors including vessel diameter, density, depth, and flow characteristics, all of which affect laser absorption and heat diffusion. Moreover, individual variations in vascular architecture and the presence of underlying conditions such as rosacea or telangiectasia can alter the skin’s responsiveness to treatment. The acute response of blood vessels to laser exposure often includes vasodilation, thrombosis, and vessel wall rupture, which are intended therapeutic outcomes in the treatment of vascular lesions. However, these responses also initiate inflammatory signaling and dermal remodeling that contribute to long-term improvements in skin texture and tone.²

The effectiveness of lasers in aesthetic dermatology is closely linked to how well these vascular responses are modulated during and after treatment. For instance, pulsed dye lasers (PDL), which emit yellow light with a high affinity for hemoglobin, have been shown to selectively damage superficial blood vessels, leading to reduced erythema and improved skin appearance in conditions like port-wine stains and poikiloderma.^2,3 Similarly, newer technologies such as Nd:YAG lasers utilize longer wavelengths to target deeper vessels, allowing for enhanced treatment of conditions involving reticular or feeder veins. In both cases, clinical efficacy is partially determined by the extent and nature of the vascular response induced.

Emerging evidence also suggests that subtherapeutic vascular stimulation by low-level laser exposure may influence angiogenesis and tissue regeneration, opening new avenues for non-ablative rejuvenation strategies. This growing understanding underscores the importance of vascular physiology in optimizing laser parameters, predicting outcomes, and managing adverse effects such as purpura, post-inflammatory hyperpigmentation, or scarring.⁴ A thorough grasp of the interplay between laser energy and vascular response is therefore essential for clinicians aiming to tailor treatments to individual patient profiles and achieve consistent, high-quality results in aesthetic dermatology.

REVIEW

The role of the cutaneous vascular response in laser-based aesthetic procedures is both foundational and multifaceted. Laser energy primarily targets hemoglobin within blood vessels, initiating controlled thermal injury that leads to vessel coagulation and subsequent clearance. This response is critical in treating vascular lesions, but it also plays a secondary role in triggering dermal remodeling processes, which contribute to overall aesthetic improvements such as enhanced skin texture and tone. The degree of vascular injury and the subsequent biological response depend on several parameters, including pulse duration, fluence, wavelength, and spot size, as well as patient-specific factors like skin type and vascular density.⁵

Moreover, post-laser vascular response influences not only treatment efficacy but also recovery and side effect profiles. For instance, excessive vascular damage can lead to purpura or post-inflammatory hyperpigmentation, particularly in individuals with darker skin types. Thus, tailoring treatment protocols to modulate the vascular response without overexposing tissue is crucial. Newer modalities, including sub-purpuric techniques and combination therapies, aim to balance vascular targeting with minimized downtime and risk. Advances in real-time imaging and feedback mechanisms further enhance precision in managing vascular response, allowing clinicians to individualize treatments more effectively and improve patient outcomes in laser aesthetics.⁶

MECHANISMS OF CUTANEOUS VASCULAR RESPONSE TO LASER EXPOSURE

Cutaneous blood vessels are central to the interaction between laser energy and skin tissue. When a vascular-targeting laser is applied to the skin, the emitted light is absorbed by hemoglobin within the vessel, converting the energy into heat. This thermal energy results in selective photothermolysis, a process where the vessel walls are denatured without causing widespread tissue injury. Specific wavelengths, especially those in the 532 nm to 1064 nm range, are chosen based on their absorption peak in oxyhemoglobin and deoxyhemoglobin. This wavelength specificity allows lasers to affect vessels at varying depths and diameters. Shorter wavelengths like 532 nm target superficial vessels, while longer wavelengths such as 1064 nm penetrate more deeply, making them suitable for larger and deeper vascular structures.⁷

Once the heat is delivered, the vessel undergoes coagulation. The thermal damage causes endothelial cell disruption and platelet aggregation, which lead to thrombus formation within the vessel lumen. The occluded vessels are then resorbed by the body over the following days to weeks. This mechanism underlies the success of lasers in treating telangiectasia, rosacea, and port-wine stains. The degree of thermal injury is determined not just by wavelength but also by pulse duration and energy fluence. Matching the laser's pulse duration with the thermal relaxation time of the vessel optimizes selective damage, avoiding injury to surrounding tissues.⁸

Aside from coagulation, laser exposure also induces secondary biological effects in the vascular endothelium and surrounding dermis. These include cytokine release, recruitment of immune cells, and activation of matrix metalloproteinases. Such responses influence post-treatment healing and skin remodeling. Vascular injury triggers vasodilation initially, followed by vessel collapse and inflammatory infiltration. Macrophages and neutrophils migrate to the injury site, contributing to cleanup and repair. The release of growth factors like VEGF can stimulate limited angiogenesis, although in many aesthetic treatments, vessel destruction is the desired outcome.⁹

Vessel size and flow dynamics further influence how blood vessels react to laser treatment. Larger vessels with high blood flow dissipate heat more efficiently, making them more resistant to thermal damage. In contrast, slower flow in small-caliber vessels allows for greater heat retention and more effective coagulation. Vessel orientation and skin thickness also affect light scattering and absorption, altering treatment response. Therefore, individualized assessment is essential before selecting laser parameters.

The Fitzpatrick skin type adds another layer of complexity. Melanin competes with hemoglobin for light absorption, especially at shorter wavelengths, increasing the risk of epidermal injury in darker skin tones. Cooling devices and longer pulse durations are often employed in such cases to protect the epidermis while still achieving vascular targeting.¹⁰

VASCULAR MODULATION AND TREATMENT OUTCOMES IN AESTHETIC PROCEDURES

Vascular modulation plays a central role in shaping the therapeutic outcomes of laser-based aesthetic interventions. The precision of targeting blood vessels within the dermis contributes directly to the efficacy and predictability of treatment. Successful outcomes are influenced not only by the immediate vessel reaction to laser exposure but also by how the skin's microcirculation adapts and reorganizes in the days following the procedure. Treatments that fail to induce the desired vascular effect often result in incomplete clearance or relapse of the condition being addressed.

Various lasers aim to modulate vessel behavior by controlling coagulation, constriction, or selective elimination. Devices such as PDL and intense pulsed light (IPL) systems are used to collapse superficial vessels or reduce erythema by inducing heat-mediated damage. Studies have demonstrated that properly calibrated energy doses can lead to lasting vessel closure, especially in disorders like facial telangiectasia and poikiloderma of Civatte.¹¹ These responses, however, are not uniform across patients. The density, size, and location of vessels, along with patient skin type, can all influence how the vascular network reacts, even under identical treatment protocols.

Clinical outcomes are also affected by the depth and type of vessel being targeted. Superficial capillaries typically respond more readily to shorter wavelengths, while deeper venous structures demand longer wavelengths with greater penetration. The use of long-pulsed Nd:YAG lasers has been effective for targeting deeper reticular veins, as demonstrated by successful outcomes in leg vein treatments with minimal adverse effects.¹² Despite delivering energy below the threshold of visible purpura, this approach still induces sufficient vascular injury to prompt thrombosis and vessel degradation over time. The ability to manipulate vascular response without relying on maximum visible signs of treatment has contributed to shorter recovery periods and higher patient satisfaction.

Post-treatment vascular remodeling is just as relevant to outcomes as the initial photothermal event. The coagulated vessels do not simply disappear; their breakdown is managed by endogenous inflammatory processes, which include macrophage activity and gradual resorption of damaged tissue. This resolution phase can influence whether pigmentation abnormalities or textural irregularities emerge. Consistency in outcomes often relies on the body’s ability to clear this residual tissue efficiently, which varies by individual physiology and immune response.^12,13

Some of the most effective protocols adjust energy delivery based on real-time skin feedback. Advances in dynamic cooling devices and multispectral imaging have enabled clinicians to monitor vessel response during the session, allowing for greater control. This shift has improved the balance between efficacy and safety, particularly in patients with mixed lesions or overlapping pigmentary and vascular components. Additionally, fractional lasers that stimulate neovascularization have been employed to indirectly improve microcirculation, which supports the repair process after ablative or non-ablative treatments.¹⁴

FACTORS INFLUENCING VASCULAR RESPONSE AND CLINICAL EFFICACY

Variability in clinical efficacy following laser-based vascular treatments often stems from complex biological and technical factors that influence how skin vasculature reacts to thermal energy. These variables can lead to unpredictable outcomes unless carefully evaluated before and during treatment. Vessel diameter, wall thickness, blood flow velocity, and depth within the dermis all interact with laser parameters to determine the nature and extent of the vascular response. Smaller vessels with slower flow rates typically absorb more heat and coagulate more efficiently, while high-flow or deeper vessels may resist thermal injury unless treated with higher fluence or adjusted pulse durations.¹⁵

Skin phototype significantly affects both efficacy and safety. Melanin competes with hemoglobin for photon absorption, especially when using lasers with shorter wavelengths such as 532 or 595 nm. In individuals with higher Fitzpatrick skin types, this increases the risk of unintended epidermal damage and post-inflammatory pigmentation changes. Protective strategies like integrated cooling systems and the use of longer wavelengths, including 755 nm or 1064 nm, have been adopted to lower these risks without compromising vessel targeting. However, balancing sufficient energy delivery to the vasculature while sparing the melanin-rich epidermis remains a clinical challenge in diverse patient populations.¹⁶

Device selection and pulse characteristics shape how vascular structures are affected. Pulse stacking, variable pulse durations, and energy density adjustments allow practitioners to tailor the treatment for specific lesions. Technologies like dual-wavelength platforms permit simultaneous or sequential targeting of superficial and deep vessels, improving the range of treatable conditions. Inconsistent parameter selection or failure to match the pulse duration with the thermal relaxation time of the vessel can lead to partial photocoagulation, insufficient thrombus formation, or even vessel recanalization. These procedural factors often separate optimal outcomes from minimal or short-lived results.¹⁷

Vascular responsiveness can also differ based on anatomical location. Areas with thinner skin or dense capillary networks, such as the face, typically respond more readily than thicker regions like the legs, where larger and deeper vessels may require repeated sessions or higher fluences. In leg vein treatments, for instance, gravity-related venous pressure and valve competence influence vessel closure rates. Histologic differences across body sites mean that a one-size-fits-all protocol does not apply in aesthetic laser treatments. Experienced clinicians often adapt their approach based on the location, vessel type, and expected healing timeline.

Pre-treatment vascular condition plays a role as well. Telangiectatic vessels associated with chronic inflammation or photodamage may exhibit increased fragility or abnormal dilation, affecting how they absorb and dissipate thermal energy. Patient-specific factors such as age, systemic vascular health, and medication use may interfere with coagulation processes and vascular healing. While technological advances provide tools to navigate these differences, careful patient assessment remains essential. Variables that influence heat absorption, blood flow dynamics, and tissue healing capacity are not always visible but heavily determine treatment trajectories. Recognizing and managing these influences allows clinicians to adjust expectations, optimize safety, and pursue more individualized treatment strategies.¹⁸

CONCLUSION

Understanding the mechanisms of cutaneous vascular response is key to improving the precision and outcomes of laser-based aesthetic procedures. Clinical efficacy depends on a balance between targeted vascular injury and safe energy delivery tailored to patient-specific factors. Advancements in laser technology continue to refine vascular modulation strategies across diverse skin types and conditions. Ongoing research will further enhance treatment personalization and long-term effectiveness.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: Not required

REFERENCES

1. 1. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524-7.
2. 2. Railan D, Parlette EC, Uebelhoer NS, Rohrer TE. Laser treatment of vascular lesions. Clin Dermatol. 2006;24(1):8-15.
3. 3. Jeon H, Bernstein LJ, Belkin DA, Ghalili S, Geronemus RG. Pulsed dye laser treatment of port-wine stains in infancy without the need for general anesthesia. JAMA Dermatol. 2019;155(4):435-41.
4. 4. Alster TS, Lupton JR. Lasers in dermatology: an overview of types and indications. Am J Clin Dermatol. 2001;2(5):291-303.
5. 5. Khatri KA, Ross V, Grevelink JM, Magro CM, Anderson RR. Comparison of erbium: YAG and carbon dioxide lasers in resurfacing of facial rhytides. Arc dermatol. 1999;135(4):391-7.
6. 6. Jasim ZF, Handley JM. Treatment of pulsed dye laser–resistant port wine stain birthmarks. J Am Acad Dermatol. 2007;57(4):677-82.
7. 7. Garden JM, Tan OT, Kerschmann R, et al. Effect of dye laser pulse duration on selective cutaneous vascular injury. J Investig Dermatol. 1986;87(5):653-7.
8. 8. Husein-ElAhmed H, Steinhoff M. Laser and light-based therapies in the management of rosacea: an updated systematic review. Lasers Med Sci. 2021;36(6):1151-60.
9. 9. Lou WW, Quintana AT, Geronemus RG, Grossman MC. Effects of topical vitamin K and retinol on laser-induced purpura on nonlesional skin. Dermatol Surg. 1999;25(12):942-4.
10. 10. Tang J, He X. Comparison of the efficacy and safety of pulsed dye laser, narrow-band intense pulsed light, and broad-band intense pulsed light in the treatment of erythematotelangiectatic rosacea. Am J Translation Res. 2025;17(7):5530.
11. 11. Nguyen L, Seeber N, Kautz G, Hartjen A, Schneider SW, Herberger K. 532‐nm potassium titanyl‐phosphate laser versus 595‐nm pulsed dye laser for port‐wine birthmarks: A prospective, randomized, split‐side study. J Eu Acad Dermatol Venereol. 2024;38(6):1140-6.
12. 12. Faurschou A, Togsverd‐Bo K, Zachariae C, Hædersdal M. Pulsed dye laser vs. intense pulsed light for port‐wine stains: a randomized side‐by‐side trial with blinded response evaluation. Br J Dermatol. 2009;160(2):359-64.
13. 13. Kołodziejczak A, Rotsztejn H. Efficacy of fractional laser, radiofrequency and IPL rejuvenation of periorbital region. Lasers Med Sci. 2022;37(2):895-903.
14. 14. Hui Q, Chang P, Guo B, Zhang Y, Tao K. The clinical efficacy of autologous platelet-rich plasma combined with ultra-pulsed fractional CO2 laser therapy for facial rejuvenation. Rejuvenation Res. 2017;20(1):25-31.
15. 15. West TB, Alster TS. Comparison of the long-pulse dye (590–595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24(2):221-6.
16. 16. Kilmer SL, Garden JM. Laser treatment of pigmented lesions and tattoos. Semin Cutan Med Surg. 2000;19(4):232-44.
17. 17. Greve B, Raulin C. Prospective study of port wine stain treatment with dye laser: comparison of two wavelengths (585 nm vs. 595 nm) and two pulse durations (0.5 milliseconds vs. 20 milliseconds). Lasers Surg Med. 2004;34(2):168-73.
18. 18. Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases. Official J Am Society Laser Med Surg. 2007;39(7):563-8.